ATOM (Atomera Incorporated Common Stock) Stock Analysis - Politician Trades

Atomera Incorporated Common Stock (ATOM) is a publicly traded Technology sector company. As of May 20, 2026, ATOM trades at $7.87 with a market cap of $309.92M and a P/E ratio of -11.28. ATOM moved +2.54% today. Year to date, ATOM is +217.37%; over the trailing twelve months it is +2.46%. Its 52-week range spans $1.89 to $17.55. Analyst consensus is buy with an average price target of $10.00. Rallies surfaces ATOM's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Which politicians traded ATOM stock?

Rallies tracks politician and congressional stock disclosures for ATOM, including purchases, sales, transaction dates, owners, and reported trade amounts when available.

ATOM Key Metrics

Key financial metrics for ATOM
MetricValue
Price$7.87
Market Cap$309.92M
P/E Ratio-11.28
EPS$-0.68
Dividend Yield0.00%
52-Week High$17.55
52-Week Low$1.89
Volume1.01M
Avg Volume0
Revenue (TTM)$135.00K
Net Income$-18.43M
Gross Margin8.89%

Latest ATOM News

Recent ATOM Insider Trades

  • Mears Robert J sold 426 (~$2.11K) on Mar 2, 2026.
  • Mears Robert J sold 863 (~$4.27K) on Mar 2, 2026.
  • Mears Robert J sold 995 (~$4.93K) on Mar 2, 2026.

ATOM Analyst Consensus

1 analysts cover ATOM: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $10.00.

Common questions about ATOM

Which politicians traded ATOM stock?
Rallies tracks politician and congressional stock disclosures for ATOM, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
Does Rallies track congressional trades in ATOM?
Yes. Rallies tracks politician and congressional stock disclosures for ATOM, including reported purchases, sales, dates, owners, and trade amounts when available.
Is ATOM research on Rallies investment advice?
No. Rallies provides research, data, and educational context for ATOM. It does not provide personalized investment advice.
ATOM

ATOM